澳门太阳游戏城app官网入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.

Virology. 2018-01; 
ShcherbikSvetlana,CarneyPaul,PearceNicholas,StevensJames,DuganVivien G,WentworthDavid E,BousseTat
Products/Services Used Details Operation
Gene Synthesis … The recN2-NA gene encoding residues 80–470 of Len/17-MDV were synthesized (GenScript USA Inc.) as a codon-optimized gene for insect cell expression and were subcloned into the baculovirus transfer vector pAcGP67B (BD Biosciences) … Get A Quote

摘要

Cold adapted influenza virus A/Leningrad/134/17/57 (H2N2) is a reliable master donor virus (Len/17-MDV) for preparing live attenuated influenza vaccines (LAIV). LAIVs are 6:2 reasortants that contain 6 segments of Len/17-MDV and the hemagglutinin (HA) and neuraminidase (NA) of contemporary circulating influenza A viruses. The problem with the classical reassortment procedure used to generate LAIVs is that there is limited selection pressure against NA of the Len/17-MDV resulting in 7:1 reassortants with desired HA only, which are not suitable LAIVs. The monoclonal antibodies (mAb) directed against the N2 of Len/17-MDV were generated. 10C4-8E7 mAb inhibits cell-to-cell spread of viruses containing the Len/17-M... More

关键词

Classical reassortment,Influenza,Live vaccine,Monoclonal antibody,Neuramini